Cinderbio
Berkeley, US · Founded 2012 · 5 employees on LinkedIn · 1 known investors
Find your way into Cinderbio
CinderBio develops HTA-Proteases, specialized enzymes for proteomics research that enable comprehensive protein analysis through orthogonal digestion approaches. The company serves life sciences and biotech researchers requiring advanced tools for protein characterization and mass spectrometry applications.
Founders & leadership
JO
Jill O FussNamed on SEC filing
SM
Steven M YannoneNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$100K disclosed across 1 round · 2019
▶$100KraisedJun 2019 · 1 investors · Other TechnologyRule 506(b)
▶$100KraisedJun 2019 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jill O FussExecutive Officer, Director, Promoter
- Steven M YannoneExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $100K
- Minimum investment
- $1
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cinderbio do?
- CinderBio develops HTA-Proteases, specialized enzymes for proteomics research that enable comprehensive protein analysis through orthogonal digestion approaches. The company serves life sciences and biotech researchers requiring advanced tools for protein characterization and mass spectrometry applications.
- Who are Cinderbio's investors?
- Cinderbio's investors include Mount Wilson Ventures.
- How much funding has Cinderbio raised?
- Cinderbio has disclosed $100K raised across 1 round.
- Where is Cinderbio headquartered?
- Cinderbio is headquartered in Berkeley, US.